Table 5.
CMC-001 | Gadobenate dimeglumine | |
---|---|---|
Total number of participants | 20 | 20 |
Participants with at least one AE | 19 (95%) | 8 (40%) |
Number of ADR/AE | 24/31 | 3/9 |
Intensity of AE (mild/moderate/severe) | 20/10/1 | 7/2/0 |
CMC-001 | Gadobenate dimeglumine | |
---|---|---|
Total number of participants | 20 | 20 |
Participants with at least one AE | 19 (95%) | 8 (40%) |
Number of ADR/AE | 24/31 | 3/9 |
Intensity of AE (mild/moderate/severe) | 20/10/1 | 7/2/0 |